SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 922.97 |
| Enterprise Value ($M) | 640.11 |
| Book Value ($M) | 277.49 |
| Book Value / Share | 8.23 |
| Price / Book | 3.33 |
| NCAV ($M) | 277.18 |
| NCAV / Share | 8.23 |
| Price / NCAV | 3.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.28 |
| Current Ratio | 19.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 292.40 |
| Assets | 292.71 |
| Liabilities | 15.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Novo Holdings A/S | |||
| 13G | Suvretta Capital Management, Llc | 6.10 | ||
| 13G | Hillhouse Capital Advisors, Ltd. | 13.40 | ||
| 13G | Fmr Llc | 6.31 | ||
| 13G | Sofinnova Venture Partners XI, L.P. | 5.10 | ||
| 13G | BlackRock, Inc. | 5.80 | 0.00 | |
| 13G | Octagon Capital Advisors LP | 5.90 | ||
| 13G | LAV Fund VI, L.P. | 6.40 | ||
| 13D | Orbimed Advisors Llc | 9.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 36,361 | 93,189 | 39.02 | |
| 27,677 | 90,361 | 30.63 | |
| 40,441 | 108,460 | 37.29 | |
| 39,814 | 105,535 | 37.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATXS – Astria Therapeutics, Inc. | AUPH – Aurinia Pharmaceuticals Inc. |
| AURA – Aura Biosciences, Inc. | AVDL – Avadel Pharmaceuticals plc |
| AVTE – Aerovate Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io